ABIOARCA biopharma, Inc.

Nasdaq www.arcabiopharma.com


$ 3.74 $ 0.40 (12.05 %)    

Wednesday, 15-May-2024 15:04:10 EDT
QQQ $ 453.37 $ -0.21 (-0.05 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 530.18 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 3.72
$ 3.49
$ 0.00 x 0
$ 0.00 x 0
$ 3.49 - $ 3.74
$ 1.56 - $ 3.88
193,275
na
53.94M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-01-2024 12-31-2023 10-K
3 10-18-2023 09-30-2023 10-Q
4 07-21-2023 06-30-2023 10-Q
5 04-24-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 10-28-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-02-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-22-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-21-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-17-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-19-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 gamestop-trader-roaring-kitty-sparks-wall-street-rally-in-heavily-shorted-stocks-what-you-need-to-know-right-now

The madness in meme stocks on Monday can be traced back to a social media post from Keith Gill, best known as "Roaring Kitt...

 arca-biopharma-q1-eps-014-down-from-009-yoy

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.14) per share. This is a 55.56 percent decrease over losses of $(...

 arca-biopharma-13d-filing-shows-adage-capital-management-lp-reported-a-828-stake-in-the-co-as-of-april-3-2024

- SEC Filing

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 why-flora-growth-shares-are-trading-lower-by-around-20-here-are-20-stocks-moving-premarket

Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch ...

 nasdaq-gains-75-points-acuity-brands-posts-upbeat-earnings

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up ...

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 crude-oil-moves-higher-ism-services-pmi-falls-in-march

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up ...

 small-cap-arca-biopharma-stock-soars-on-merger-pact-the-details

ARCA Biopharma and Oruka Therapeutics merge, focusing on novel biologics for chronic skin diseases like plaque psoriasis. ORKA-...

 us-stocks-edge-lower-private-employment-tops-views

U.S. stocks traded lower this morning, following the release of ADP jobs data on Wednesday. Following the market opening Wedne...

Core News & Articles
Market-Moving News for April 3rd
04/03/2024 12:40:57

ABIO: 165% | ARCA Biopharma shares are trading higher after the company and Oruka Therapeutics announced a merger agreement. L...

 arca-biopharma-and-oruka-therapeutics-announce-merger-agreement-the-deal-is-expected-to-close-in-q3-of-2024

Merger to create a company focused on advancing Oruka's portfolio of novel biologics that aim to redefine the standard of...

 arca-biopharma-q3-eps-010-up-from-016-yoy

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.10) per share. This is a 37.5 percent increase over losses of $(0...

 arca-biopharma-q2-eps-010-up-from-022-yoy

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.10) per share. This is a 54.55 percent increase over losses of $(...

 arca-biopharma-q1-eps-009-up-from-023-yoy

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.09) per share. This is a 60.87 percent increase over losses of $(...

 arca-biopharma-fy-eps-069-up-from-139-yoy-cash--cash-equivalents-of-424m-sufficient-to-fund-its-operations-through-the-middle-of-2024

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.69) per share. This is a 50.36 percent increase over losses of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION